Amit Soni
Pediatric Hematology-Oncology · Orange, CANPI 1659539211
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Biomarin Pharmaceutical Inc. at 42.5% of the total. Among pediatric hematology-oncology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 87 payments — averaging $805.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$30K
- Novo Nordisk$15K
- Takeda Pharmaceuticals U.S.A., Inc.$7K
- CSL Behring$4K
- Bayer$3K
- Sanofi-aventis U.S. LLC$3K
- plus $8K from 13 others
Across 63 payments — averaging $3111.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$107K
- Bioverativ Therapeutics Inc.$53K
- Bausch Health US, LLC$15K
- Bayer$12K
- Sanofi$4K
- Spark Therapeutics, Inc.$4K
- plus $1K from 2 others
What the payments were for
- Consulting fees$31,12244%
- Speaking & faculty fees$21,47731%
- Travel & lodging$14,98121%
- Food & beverage$1,8133%
- Education$6871%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 29 | $29,786 |
| Novo Nordisk | 14 | $14,633 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $7,147 |
| CSL Behring | 3 | $4,370 |
| Bayer | 2 | $3,091 |
| Sanofi-aventis U.S. LLC | 5 | $2,727 |
| Bioverativ Therapeutics Inc. | 1 | $2,458 |
| Shire North American Group Inc | 11 | $2,274 |
| Sanofi | 2 | $1,862 |
| Pfizer | 2 | $1,142 |
| AstraZeneca | 2 | $281 |
| Octapharma USA, Inc. | 2 | $76 |
| Vertex | 2 | $57 |
| Novartis | 3 | $54 |
| Eurofins Viracor, LLC | 1 | $37 |
| Genentech USA, Inc. | 1 | $25 |
| Bio Products Laboratory USA, Inc. | 1 | $23 |
| Global Blood Therapeutics, Inc. | 1 | $19 |
| Chiesi USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$70,079 in reported general payments places this provider in the 90th percentile of 307 pediatric hematology-oncology providers in California.
See all pediatric hematology-oncology providers in California →
Other pediatric hematology-oncology in Orange
- Vanessa Salinas-LunaOrange$344K
- Arash MahajerinOrange$249K
- Esteban GomezOrange$56K
- Diane NugentOrange$55K
- van HuynhOrange$37K
- Mariko SatoOrange$21K
- Philip PizzoPalo Alto$2.6M
- Vinod BalasaMadera$508K
- Akshat JainRedlands$447K
- Noah FedermanLos Angeles$399K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.